Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
12. Juni 2024 07:05 ET
|
Clearside Biomedical, Inc.
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - Robust Safety Profile and Encouraging Efficacy Data Reported Utilizing SCS Microinjector® - ...
Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
09. März 2023 16:05 ET
|
Clearside Biomedical, Inc.
- Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2 2023 - - Medical Meeting Presentations Highlight Significant Potential of CLS-AX Based on Positive OASIS Phase 1/2a Safety...
Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery
11. September 2020 08:30 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
13. November 2012 13:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 13, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the 12-month results of the...
Transcend Medical Launches the Transcend Vold Gonio Lens (TVG) for Improved Visualization During Micro-Invasive Glaucoma Surgery
12. November 2012 09:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 12, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, today announced the commercial...
Transcend Medical Announces Four Scientific Abstracts at the American Society of Cataract and Refractive Surgery Annual Meeting
21. April 2012 09:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Apr 21, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced that the CyPass...